CD8A and hepatocellular carcinoma: For example, TLS-like structures associated with hepatocellular carcinoma (HCC) predict a poor prognosis for patients (25), and a high ratio of CD8+ T cells to CD20+ B cells is associated with the progression of prostate cancer (26); these findings are indicative of TLS heterogeneity in tumors.